145 related articles for article (PubMed ID: 10227708)
1. Distribution characteristics of levofloxacin and grepafloxacin in rat kidney.
Ito T; Yano I; Masuda S; Hashimoto Y; Inui K
Pharm Res; 1999 Apr; 16(4):534-9. PubMed ID: 10227708
[TBL] [Abstract][Full Text] [Related]
2. Secretory mechanisms of grepafloxacin and levofloxacin in the human intestinal cell line caco-2.
Yamaguchi H; Yano I; Hashimoto Y; Inui KI
J Pharmacol Exp Ther; 2000 Oct; 295(1):360-6. PubMed ID: 10992002
[TBL] [Abstract][Full Text] [Related]
3. Transport characteristics of grepafloxacin and levofloxacin in the human intestinal cell line Caco-2.
Yamaguchi H; Yano I; Saito H; Inui K
Eur J Pharmacol; 2001 Nov; 431(3):297-303. PubMed ID: 11730721
[TBL] [Abstract][Full Text] [Related]
4. Transepithelial transport of levofloxacin in the isolated perfused rat kidney.
Ito T; Yano I; Hashimoto Y; Inui K
Pharm Res; 2000 Feb; 17(2):236-41. PubMed ID: 10751041
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic role of P-glycoprotein in oral bioavailability and intestinal secretion of grepafloxacin in vivo.
Yamaguchi H; Yano I; Saito H; Inui K
J Pharmacol Exp Ther; 2002 Mar; 300(3):1063-9. PubMed ID: 11861816
[TBL] [Abstract][Full Text] [Related]
6. Comparison of antimycobacterial activity of grepafloxacin against Mycobacterium avium with that of levofloxacin: accumulation of grepafloxacin in human macrophages.
Hirota M; Totsu T; Adachi F; Kamikawa K; Watanabe J; Kanegasaki S; Nakata K
J Infect Chemother; 2001 Mar; 7(1):16-21. PubMed ID: 11406752
[TBL] [Abstract][Full Text] [Related]
7. Effect of cisplatin-induced acute renal failure on bioavailability and intestinal secretion of quinolone antibacterial drugs in rats.
Yamaguchi H; Yano I; Saito H; Inui K
Pharm Res; 2004 Feb; 21(2):330-8. PubMed ID: 15032316
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of renal tubular secretion and reabsorption of levofloxacin in rats.
Yano I; Ito T; Takano M; Inui K
Pharm Res; 1997 Apr; 14(4):508-11. PubMed ID: 9144740
[TBL] [Abstract][Full Text] [Related]
9. Limited distribution of new quinolone antibacterial agents into brain caused by multiple efflux transporters at the blood-brain barrier.
Tamai I; Yamashita J; Kido Y; Ohnari A; Sai Y; Shima Y; Naruhashi K; Koizumi S; Tsuji A
J Pharmacol Exp Ther; 2000 Oct; 295(1):146-52. PubMed ID: 10991972
[TBL] [Abstract][Full Text] [Related]
10. Ultrastructural characterization of murine limb buds after in vitro exposure to grepafloxacin and other fluoroquinolones.
Shakibaei M; Baumann-Wilschke I; Rücker M; Stahlmann R
Arch Toxicol; 2002 Jan; 75(11-12):725-33. PubMed ID: 11876506
[TBL] [Abstract][Full Text] [Related]
11. Transport of levofloxacin in the OK kidney epithelial cell line: interaction with p-aminohippurate transport.
Matsuo Y; Yano I; Habu Y; Katsura T; Hashimoto Y; Inui K
Pharm Res; 2001 May; 18(5):573-8. PubMed ID: 11465410
[TBL] [Abstract][Full Text] [Related]
12. Transport of quinolone antibacterial drugs in a kidney epithelial cell line, LLC-PK1.
Matsuo Y; Yano I; Ito T; Hashimoto Y; Inui K
J Pharmacol Exp Ther; 1998 Nov; 287(2):672-8. PubMed ID: 9808695
[TBL] [Abstract][Full Text] [Related]
13. Lung tissue distribution after intravenous administration of grepafloxacin: comparative study with levofloxacin.
Yamamoto H; Koizumi T; Hirota M; Kaneki T; Ogasawara H; Yamazaki Y; Fujimoto K; Kubo K
Jpn J Pharmacol; 2002 Jan; 88(1):63-8. PubMed ID: 11855679
[TBL] [Abstract][Full Text] [Related]
14. Cotransport of macrolide and fluoroquinolones, a beneficial interaction reversing P-glycoprotein efflux.
Sikri V; Pal D; Jain R; Kalyani D; Mitra AK
Am J Ther; 2004; 11(6):433-42. PubMed ID: 15543082
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of grepafloxacin after oral administration of single and repeat doses in healthy young males.
Efthymiopoulos C; Bramer SL; Maroli A
Clin Pharmacokinet; 1997; 33 Suppl 1():1-8. PubMed ID: 9433650
[TBL] [Abstract][Full Text] [Related]
16. Comparative bactericidal activities of ciprofloxacin, clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, and trovafloxacin against Streptococcus pneumoniae in a dynamic in vitro model.
Klepser ME; Ernst EJ; Petzold CR; Rhomberg P; Doern GV
Antimicrob Agents Chemother; 2001 Mar; 45(3):673-8. PubMed ID: 11181341
[TBL] [Abstract][Full Text] [Related]
17. Carrier-mediated hepatic uptake of quinolone antibiotics in the rat.
Sasabe H; Terasaki T; Tsuji A; Sugiyama Y
J Pharmacol Exp Ther; 1997 Jul; 282(1):162-71. PubMed ID: 9223551
[TBL] [Abstract][Full Text] [Related]
18. Effect of renal impairment on the pharmacokinetics of grepafloxacin.
Efthymiopoulos C; Bramer SL; Maroli A; Gambertoglio JG
Clin Pharmacokinet; 1997; 33 Suppl 1():32-8. PubMed ID: 9433654
[TBL] [Abstract][Full Text] [Related]
19. [Influence of ion pump-inhibiting drugs on the accumulation of ofloxacin and grepafloxacin in human polymorphonuclear leukocytes].
Orero A; Cantón E; Pemán J; Velert MM; Bermejo MV
Rev Esp Quimioter; 2002 Dec; 15(4):352-9. PubMed ID: 12587041
[TBL] [Abstract][Full Text] [Related]
20. Interaction of ofloxacin with organic cation transport system in rat renal brush-border membranes.
Okano T; Maegawa H; Inui K; Hori R
J Pharmacol Exp Ther; 1990 Dec; 255(3):1033-7. PubMed ID: 2175794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
